| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/13/2008 | WO2008036792A3 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 11/13/2008 | WO2008034270A3 X-ray contrast agent for post-mortem experimental and diagnostic angiography |
| 11/13/2008 | WO2007123992A3 Infection model for developing chemotherapeutic agents |
| 11/13/2008 | WO2007118245A3 Methods and compositions related to adenoassociated virus-phage particles |
| 11/13/2008 | WO2007076848A3 Diagnostic substance and method for the analysis of metabolism processes in the brain |
| 11/13/2008 | US20080281083 Integrin binding protein p80 for use as evaluative tool in tumor diagnostics |
| 11/13/2008 | US20080279783 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production |
| 11/13/2008 | US20080279782 Polymers conjugated with platinum drugs |
| 11/13/2008 | US20080279781 Glycosylated Carboranylporphyrins and Uses Thereof |
| 11/13/2008 | US20080279780 one or more red or near infrared emitting fluorescent moieties covalently coupled to a chlorotoxin; conjugate having a prolonged half-life in vivo |
| 11/13/2008 | US20080279779 CT tomographic imaging process and system |
| 11/13/2008 | US20080279778 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| 11/13/2008 | US20080279777 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 11/13/2008 | US20080279776 Photosensitizers and MRI Enhancers |
| 11/13/2008 | US20080279775 Benztropinamine Analogs as Dopamine Uptake Inhibitors |
| 11/13/2008 | US20080279774 Perturbed Membrane-Binding Compounds And Methods Of Using The Same |
| 11/13/2008 | US20080279771 Novel Imaging Agents for Cancer |
| 11/13/2008 | US20080279769 Enzyme Inhibitor Imaging Agents |
| 11/13/2008 | US20080279768 Bifunctional Metal Chelating Conjugates |
| 11/13/2008 | US20080279765 targeting the mannose-6-phosphate (M6P) receptor suitable for the non-invasive visualization |
| 11/13/2008 | US20080279764 Method and composition for treating cancer |
| 11/12/2008 | EP1990063A1 Tumor-selective fluorescent dye |
| 11/12/2008 | EP1990055A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 11/12/2008 | EP1990040A1 Nanoparticle delivery vehicle |
| 11/12/2008 | EP1989179A1 Contrast agents |
| 11/12/2008 | EP1989178A1 Contrast agents |
| 11/12/2008 | EP1988928A1 Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance |
| 11/12/2008 | EP1988927A2 Engineered antibody-stress protein fusions |
| 11/12/2008 | EP1988925A2 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 11/12/2008 | EP1755685A4 Methods for autologous stem cell transplantation |
| 11/12/2008 | EP1414994B9 Vaccinia virus for diagnosis and therapy of tumors |
| 11/12/2008 | CN101304767A Targeted contrast agents and methods for targeting contrast agents |
| 11/12/2008 | CN101301479A Tumor-targeted developing composition for magnetic resonance image-forming diagnose and preparation thereof |
| 11/12/2008 | CN101301223A Rat chills and fever approach behavior determinator |
| 11/12/2008 | CN100431614C Paramagnetic metal coordination compound magnetic resonance imaging contrast medium with narrow-leaved oleaster polyose modification |
| 11/11/2008 | US7449236 Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
| 11/11/2008 | US7449192 Therapy for bladder infections |
| 11/11/2008 | US7449186 administering monoclonal antibodies to vascular cell adhesion mollecules (VCAM-1), to decrease VCAM-1 mediated adhesion between the bone marrow stromal cell and the cell expressing very late antigen-4 (VLA-4); immunomodulation to promote lymphocyte adhesion to endothelial cells |
| 11/11/2008 | US7449171 Measurement biosynthesis of metabolism product; isotopes labeled |
| 11/06/2008 | WO2008134734A2 Encapsulated contrast agents |
| 11/06/2008 | WO2008134662A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 11/06/2008 | WO2008134618A2 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
| 11/06/2008 | WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 11/06/2008 | WO2008133664A2 Carboranylporphyrins and uses thereof |
| 11/06/2008 | WO2008132750A1 Clean margin assessment tool |
| 11/06/2008 | WO2008132666A1 T1 reduction in 19f magnetic resonance imaging (mri) |
| 11/06/2008 | WO2008132433A1 Fluorinated lanthanide probes for 19f magnetic resonance applications |
| 11/06/2008 | WO2008109689A3 Methods for identifying agents of use in treating obesity and diabetes |
| 11/06/2008 | WO2008104271A3 Imaging probes |
| 11/06/2008 | WO2008087445A3 Magnetic resonance imaging |
| 11/06/2008 | WO2008082545A3 Imaging using radioactive monocations in combination with a receptor binding ligand that stimulates the influx of cations |
| 11/06/2008 | WO2008073984A3 Nmdar biomarkers for diagnosing and treating cerebral ischemia |
| 11/06/2008 | WO2008067079A3 Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
| 11/06/2008 | WO2007146372A3 Novel therapeutic and diagnostic products and methods |
| 11/06/2008 | WO2007082154A3 B7-h1 and b7-h4 in cancer |
| 11/06/2008 | US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 11/06/2008 | US20080274097 Using ultrasonic vibration at treatment sites to enhance efficacy of therapeutic treatment |
| 11/06/2008 | US20080274059 Mite fusion proteins |
| 11/06/2008 | US20080274058 substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease |
| 11/06/2008 | US20080274057 Staudinger Reaction in Imaging and Therapy and Kits for Use in Imaging and Therapy |
| 11/06/2008 | US20080274056 Nanoparticle delivery systems for membrane-integrating peptides |
| 11/06/2008 | US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells |
| 11/06/2008 | US20080274054 Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof |
| 11/06/2008 | US20080274052 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide |
| 11/06/2008 | US20080274050 Labelled Adrenomedullin Derivatives and Their Use for Imaging and Therapy |
| 11/06/2008 | US20080274044 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness |
| 11/06/2008 | CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 11/05/2008 | EP1987847A1 Novel high viscosity embolizing compositions |
| 11/05/2008 | EP1987846A1 Diagnostic marker |
| 11/05/2008 | EP1987764A1 Fluorescence-mediated molecular tomography |
| 11/05/2008 | EP1987724A1 Food and process for producing food |
| 11/05/2008 | EP1986993A1 Contrast agents |
| 11/05/2008 | EP1986702A2 Hyperpolarization methods, systems and compositions |
| 11/05/2008 | EP1986701A2 Process for using optical agents |
| 11/05/2008 | EP1986700A2 The staudinger reaction in imaging and therapy and kits for use in imaging and therapy |
| 11/05/2008 | EP1986680A2 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 11/05/2008 | EP1109937B1 METHOD OF DIAGNOSING, MONITORING, STAGING, and IMAGING VARIOUS CANCERS |
| 11/05/2008 | CN101300032A Nanoparticle-based imaging agents for X-ray/computed tomography |
| 11/05/2008 | CN101297975A Contrast agent for MR cholangiopancreatography |
| 11/04/2008 | US7445904 Transgenic animal models comprising misssense mutations in gene coding cysteine string protein (CSP) for diagnosis, prevention and treatment of nervous system disorders |
| 11/04/2008 | US7445784 Apoptosis of rectum and prostate cancer |
| 11/04/2008 | US7445767 Using water soluble dyes; contrast media for fluorescence |
| 11/04/2008 | US7445766 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture |
| 11/04/2008 | US7445765 Active ingredient a technetium-99m nitride heterocomplex comprising technetium-99m nitride and two different ligands coordinated therewith, i.e., a bisphosphinoamine compound as a pi electron acceptor and a bidentate ligand as a pi electron |
| 11/04/2008 | US7445764 Carrier-drug conjugate |
| 10/30/2008 | WO2008131024A1 Iodo-hexose compounds useful to treat cancer |
| 10/30/2008 | WO2008130181A1 Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
| 10/30/2008 | WO2008101231A3 Methods and compositions for treating and diagnosing kidney disease |
| 10/30/2008 | WO2008092059A3 Tantalum oxide nanoparticles as imaging agents for x-ray/ computed tomography and methods for making same |
| 10/30/2008 | WO2008050255A3 Contrast agents for detecting prostate cancer |
| 10/30/2008 | WO2008036175A3 Methods for predicting psychotropic drugs which elicit weight gain |
| 10/30/2008 | WO2007136614A3 Assays and methods for the diagnosis and progression of alzheimer's disease using a multi-analyte marker panel |
| 10/30/2008 | WO2007136413A3 Biocompatible fluorescent metal oxide nanoparticles |
| 10/30/2008 | WO2007092598A3 Novel neurological function of mpkci |
| 10/30/2008 | WO2007083287A3 Test method for assessing irritation of skin |
| 10/30/2008 | US20080269668 Medical Microbubble Generation |
| 10/30/2008 | US20080269112 Antineoplastic Agents Targeted via Glut Transporters |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/30/2008 | US20080267969 Treatment of Pulmonary Hypertension Using an Agent That Inhibits a Tissue Factor Pathway |
| 10/30/2008 | US20080267884 Contrast Agents and Diagnostic Compositions Based on Iodine-Containing Cyanuric Acid Derivatives |